Global Type 1 Diabetes Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • receipt Report ID : 148654
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 121
  • list Pharmaceuticals and Healthcare

Type 1 diabetes is a form of diabetes mellitus in which very little or no insulin is produced by the pancreas.

Scope of the Report:

The global type 1 diabetes market is expected to grow modestly during the forecast period owing to growing incidence and prevalence of diabetes and cohesive government policies.

The global Type 1 Diabetes market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Type 1 Diabetes.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

This report studies the Type 1 Diabetes market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Type 1 Diabetes market by product type and applications/end industries.

Market Segment by Companies, this report covers

Abbott

Bayer

Eli Lilly

BD

Johnson & Johnson

Merck

Pfizer

AstraZeneca

Roche

Smiths Medical

Medtronic

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Rapid-acting

Long-acting

Premix

Market Segment by Applications, can be divided into

Hospitals

Diagnostic clinics

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Type 1 Diabetes Market Overview

1.1 Product Overview and Scope of Type 1 Diabetes

1.2 Classification of Type 1 Diabetes by Types

1.2.1 Global Type 1 Diabetes Revenue Comparison by Types (2017-2023)

1.2.2 Global Type 1 Diabetes Revenue Market Share by Types in 2017

1.2.3 Rapid-acting

1.2.4 Long-acting

1.2.5 Premix

1.3 Global Type 1 Diabetes Market by Application

1.3.1 Global Type 1 Diabetes Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospitals

1.3.3 Diagnostic clinics

1.4 Global Type 1 Diabetes Market by Regions

1.4.1 Global Type 1 Diabetes Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Type 1 Diabetes Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Type 1 Diabetes Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Type 1 Diabetes Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Type 1 Diabetes Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Type 1 Diabetes Status and Prospect (2013-2023)

1.5 Global Market Size of Type 1 Diabetes (2013-2023)

2 Manufacturers Profiles

2.1 Abbott

2.1.1 Business Overview

2.1.2 Type 1 Diabetes Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Abbott Type 1 Diabetes Revenue, Gross Margin and Market Share (2016-2017)

2.2 Bayer

2.2.1 Business Overview

2.2.2 Type 1 Diabetes Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Bayer Type 1 Diabetes Revenue, Gross Margin and Market Share (2016-2017)

2.3 Eli Lilly

2.3.1 Business Overview

2.3.2 Type 1 Diabetes Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Eli Lilly Type 1 Diabetes Revenue, Gross Margin and Market Share (2016-2017)

2.4 BD

2.4.1 Business Overview

2.4.2 Type 1 Diabetes Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 BD Type 1 Diabetes Revenue, Gross Margin and Market Share (2016-2017)

2.5 Johnson & Johnson

2.5.1 Business Overview

2.5.2 Type 1 Diabetes Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Johnson & Johnson Type 1 Diabetes Revenue, Gross Margin and Market Share (2016-2017)

2.6 Merck

2.6.1 Business Overview

2.6.2 Type 1 Diabetes Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Merck Type 1 Diabetes Revenue, Gross Margin and Market Share (2016-2017)

2.7 Pfizer

2.7.1 Business Overview

2.7.2 Type 1 Diabetes Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Pfizer Type 1 Diabetes Revenue, Gross Margin and Market Share (2016-2017)

2.8 AstraZeneca

2.8.1 Business Overview

2.8.2 Type 1 Diabetes Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 AstraZeneca Type 1 Diabetes Revenue, Gross Margin and Market Share (2016-2017)

2.9 Roche

2.9.1 Business Overview

2.9.2 Type 1 Diabetes Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Roche Type 1 Diabetes Revenue, Gross Margin and Market Share (2016-2017)

2.10 Smiths Medical

2.10.1 Business Overview

2.10.2 Type 1 Diabetes Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Smiths Medical Type 1 Diabetes Revenue, Gross Margin and Market Share (2016-2017)

2.11 Medtronic

2.11.1 Business Overview

2.11.2 Type 1 Diabetes Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Medtronic Type 1 Diabetes Revenue, Gross Margin and Market Share (2016-2017)

3 Global Type 1 Diabetes Market Competition, by Players

3.1 Global Type 1 Diabetes Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Type 1 Diabetes Players Market Share

3.2.2 Top 10 Type 1 Diabetes Players Market Share

3.3 Market Competition Trend

4 Global Type 1 Diabetes Market Size by Regions

4.1 Global Type 1 Diabetes Revenue and Market Share by Regions

4.2 North America Type 1 Diabetes Revenue and Growth Rate (2013-2018)

4.3 Europe Type 1 Diabetes Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Type 1 Diabetes Revenue and Growth Rate (2013-2018)

4.5 South America Type 1 Diabetes Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Type 1 Diabetes Revenue and Growth Rate (2013-2018)

5 North America Type 1 Diabetes Revenue by Countries

5.1 North America Type 1 Diabetes Revenue by Countries (2013-2018)

5.2 USA Type 1 Diabetes Revenue and Growth Rate (2013-2018)

5.3 Canada Type 1 Diabetes Revenue and Growth Rate (2013-2018)

5.4 Mexico Type 1 Diabetes Revenue and Growth Rate (2013-2018)

6 Europe Type 1 Diabetes Revenue by Countries

6.1 Europe Type 1 Diabetes Revenue by Countries (2013-2018)

6.2 Germany Type 1 Diabetes Revenue and Growth Rate (2013-2018)

6.3 UK Type 1 Diabetes Revenue and Growth Rate (2013-2018)

6.4 France Type 1 Diabetes Revenue and Growth Rate (2013-2018)

6.5 Russia Type 1 Diabetes Revenue and Growth Rate (2013-2018)

6.6 Italy Type 1 Diabetes Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Type 1 Diabetes Revenue by Countries

7.1 Asia-Pacific Type 1 Diabetes Revenue by Countries (2013-2018)

7.2 China Type 1 Diabetes Revenue and Growth Rate (2013-2018)

7.3 Japan Type 1 Diabetes Revenue and Growth Rate (2013-2018)

7.4 Korea Type 1 Diabetes Revenue and Growth Rate (2013-2018)

7.5 India Type 1 Diabetes Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Type 1 Diabetes Revenue and Growth Rate (2013-2018)

8 South America Type 1 Diabetes Revenue by Countries

8.1 South America Type 1 Diabetes Revenue by Countries (2013-2018)

8.2 Brazil Type 1 Diabetes Revenue and Growth Rate (2013-2018)

8.3 Argentina Type 1 Diabetes Revenue and Growth Rate (2013-2018)

8.4 Colombia Type 1 Diabetes Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Type 1 Diabetes by Countries

9.1 Middle East and Africa Type 1 Diabetes Revenue by Countries (2013-2018)

9.2 Saudi Arabia Type 1 Diabetes Revenue and Growth Rate (2013-2018)

9.3 UAE Type 1 Diabetes Revenue and Growth Rate (2013-2018)

9.4 Egypt Type 1 Diabetes Revenue and Growth Rate (2013-2018)

9.5 Nigeria Type 1 Diabetes Revenue and Growth Rate (2013-2018)

9.6 South Africa Type 1 Diabetes Revenue and Growth Rate (2013-2018)

10 Global Type 1 Diabetes Market Segment by Type

10.1 Global Type 1 Diabetes Revenue and Market Share by Type (2013-2018)

10.2 Global Type 1 Diabetes Market Forecast by Type (2018-2023)

10.3 Rapid-acting Revenue Growth Rate (2013-2023)

10.4 Long-acting Revenue Growth Rate (2013-2023)

10.5 Premix Revenue Growth Rate (2013-2023)

11 Global Type 1 Diabetes Market Segment by Application

11.1 Global Type 1 Diabetes Revenue Market Share by Application (2013-2018)

11.2 Type 1 Diabetes Market Forecast by Application (2018-2023)

11.3 Hospitals Revenue Growth (2013-2018)

11.4 Diagnostic clinics Revenue Growth (2013-2018)

12 Global Type 1 Diabetes Market Size Forecast (2018-2023)

12.1 Global Type 1 Diabetes Market Size Forecast (2018-2023)

12.2 Global Type 1 Diabetes Market Forecast by Regions (2018-2023)

12.3 North America Type 1 Diabetes Revenue Market Forecast (2018-2023)

12.4 Europe Type 1 Diabetes Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Type 1 Diabetes Revenue Market Forecast (2018-2023)

12.6 South America Type 1 Diabetes Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Type 1 Diabetes Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Type 1 Diabetes Picture

Table Product Specifications of Type 1 Diabetes

Table Global Type 1 Diabetes and Revenue (Million USD) Market Split by Product Type

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery